Priority Date: 19.07.12 (US 201261673639P)

HUMAN BTNL3 PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES AND USES THEREOF

  • Application ID: EP13742802
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

operating since 2000
Headquarter in Munich
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB and 226 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 19.07.2012 - Priority Date (US 201261673639P)
  • 23.01.2014 - Publication A1 (WO2014015148)
  • 27.05.2015 - Publication A1 (EP2875046)